Type |
Details |
Score |
Strain |
Attribute String: |
coisogenic, mutant strain, spontaneous mutation |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Dab1/Dab1 |
Background: |
CBA/J-Dab1/GrsrJ |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Dab1/Dab1 |
Background: |
involves: C57BL/6 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
HT Experiment |
|
Experiment Type: |
transcription profiling by array |
Study Type: |
WT vs. Mutant |
Source: |
GEO |
|
•
•
•
•
•
|
HT Experiment |
Series Id: |
GSE22758 |
Experiment Type: |
transcription profiling by array |
Study Type: |
WT vs. Mutant |
Source: |
ArrayExpress |
|
•
•
•
•
•
|
Allele |
Name: |
disabled 1; scrambler |
Allele Type: |
Spontaneous |
|
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant stock |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant stock, spontaneous mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain |
|
•
•
•
•
•
|
Strain |
Attribute String: |
F1 hybrid, mutant stock |
|
•
•
•
•
•
|
Strain |
Attribute String: |
F1 hybrid, mutant stock |
|
•
•
•
•
•
|
Strain |
Attribute String: |
F1 hybrid, mutant stock |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, spontaneous mutation |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Dab1/Dab1 |
Background: |
involves: C3H * C57BL/6J |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Dab1/Dab1 |
Background: |
involves: C3HeB/FeJ * DC/Le |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Dab1/Dab1 |
Background: |
involves: C3HeB/FeJ * DC/LeJ |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Dab1/Dab1 |
Background: |
involves: C3HeB/FeJ * C57BL/6J * DC/Le |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Dab1/Dab1<+> |
Background: |
involves: C3HeB/FeJ * C57BL/6J * DC/Le |
Zygosity: |
ht |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Dab1/Dab1 |
Background: |
involves: DC/Le |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Hocevar BA |
Year: |
2003 |
Journal: |
EMBO J |
Title: |
Regulation of the Wnt signaling pathway by disabled-2 (Dab2). |
Volume: |
22 |
Issue: |
12 |
Pages: |
3084-94 |
|
•
•
•
•
•
|
Publication |
First Author: |
Maurer ME |
Year: |
2006 |
Journal: |
J Cell Sci |
Title: |
The adaptor protein Dab2 sorts LDL receptors into coated pits independently of AP-2 and ARH. |
Volume: |
119 |
Issue: |
Pt 20 |
Pages: |
4235-46 |
|
•
•
•
•
•
|
Publication |
First Author: |
Le N |
Year: |
1998 |
Journal: |
Mol Cell Biol |
Title: |
Disabled is a putative adaptor protein that functions during signaling by the sevenless receptor tyrosine kinase. |
Volume: |
18 |
Issue: |
8 |
Pages: |
4844-54 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhoul J |
Year: |
2005 |
Journal: |
Cancer Res |
Title: |
The role of DOC-2/DAB2 in modulating androgen receptor-mediated cell growth via the nongenomic c-Src-mediated pathway in normal prostatic epithelium and cancer. |
Volume: |
65 |
Issue: |
21 |
Pages: |
9906-13 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hocevar BA |
Year: |
2001 |
Journal: |
EMBO J |
Title: |
The adaptor molecule Disabled-2 links the transforming growth factor beta receptors to the Smad pathway. |
Volume: |
20 |
Issue: |
11 |
Pages: |
2789-801 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gertler FB |
Year: |
1993 |
Journal: |
Genes Dev |
Title: |
Dosage-sensitive modifiers of Drosophila abl tyrosine kinase function: prospero, a regulator of axonal outgrowth, and disabled, a novel tyrosine kinase substrate. |
Volume: |
7 |
Issue: |
3 |
Pages: |
441-53 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
This entry represents the protein disabled (DAB) and related proteins. It includes DAB from Drosophila melanogaster and its mammlian homologues, DAB1 and DAB2 (also known as DOC1 and DOC2). This group of proteins are adapter proteins that play roles in development. In Drosophila melanogaster, DAB acts as an adapter protein for SH2-domain containing proteins in the sevenless (sev) signalling pathway []. Together with Abl, it is involved in embryonic neural development []. In mammals, DAB1 is implicated in neuronal development []. In humans, DAB2 is an adapter protein that functions as clathrin-associated sorting protein (CLASP) required for clathrin-mediated endocytosis of selected cargo proteins []. It is involved in several signalling pathways and plays an important part in cell growth and development [, , ]. |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant stock |
|
•
•
•
•
•
|
Publication |
First Author: |
Xie D |
Year: |
2009 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis. |
Volume: |
106 |
Issue: |
47 |
Pages: |
19878-83 |
|
•
•
•
•
•
|
Publication |
First Author: |
Harrison SC |
Year: |
2012 |
Journal: |
Eur Heart J |
Title: |
Association of a sequence variant in DAB2IP with coronary heart disease. |
Volume: |
33 |
Issue: |
7 |
Pages: |
881-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang H |
Year: |
2004 |
Journal: |
J Biol Chem |
Title: |
AIP1/DAB2IP, a novel member of the Ras-GAP family, transduces TRAF2-induced ASK1-JNK activation. |
Volume: |
279 |
Issue: |
43 |
Pages: |
44955-65 |
|
•
•
•
•
•
|
Publication |
First Author: |
Duggan D |
Year: |
2007 |
Journal: |
J Natl Cancer Inst |
Title: |
Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. |
Volume: |
99 |
Issue: |
24 |
Pages: |
1836-44 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gretarsdottir S |
Year: |
2010 |
Journal: |
Nat Genet |
Title: |
Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm. |
Volume: |
42 |
Issue: |
8 |
Pages: |
692-7 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
DAB-2 interacting protein (Dab2IP) is a GTPase activating protein involved in the regulation of multiple signalling pathways. Dab2IP regulates PI3K-AKT signalling and functions as a tumour suppressor. It modulates the balance between phosphatidylinositol 3-kinase (PI3K) mediated cell survival and ASK1 mediated apoptosis [, ]. Besides its function as a tumour suppressor, Dab2IP is also highly expressed in the brain, where it interacts with Dab1 (Disabled homologue 1), a key mediator of the Reelin pathway that controls several aspects of brain development and function [, , ]. It also functions as an inhibitor in VEGFR2-mediated adaptative angiogenesis [].Dab2IP has been associated with metastatic prostate cancer [], abdominal aortic aneurysms []and coronary heart disease []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Hack I |
Year: |
2007 |
Journal: |
Development |
Title: |
Divergent roles of ApoER2 and Vldlr in the migration of cortical neurons. |
Volume: |
134 |
Issue: |
21 |
Pages: |
3883-91 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lanjakornsiripan D |
Year: |
2018 |
Journal: |
Nat Commun |
Title: |
Layer-specific morphological and molecular differences in neocortical astrocytes and their dependence on neuronal layers. |
Volume: |
9 |
Issue: |
1 |
Pages: |
1623 |
|
•
•
•
•
•
|
Publication |
First Author: |
Blake SM |
Year: |
2008 |
Journal: |
EMBO J |
Title: |
Thrombospondin-1 binds to ApoER2 and VLDL receptor and functions in postnatal neuronal migration. |
Volume: |
27 |
Issue: |
22 |
Pages: |
3069-80 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lopera F |
Year: |
2023 |
Journal: |
Nat Med |
Title: |
Resilience to autosomal dominant Alzheimer's disease in a Reelin-COLBOS heterozygous man. |
Volume: |
29 |
Issue: |
5 |
Pages: |
1243-1252 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bar I |
Year: |
2000 |
Journal: |
Trends Neurosci |
Title: |
The evolution of cortical development. An hypothesis based on the role of the Reelin signaling pathway. |
Volume: |
23 |
Issue: |
12 |
Pages: |
633-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lambert de Rouvroit C |
Year: |
1999 |
Journal: |
Exp Neurol |
Title: |
Evolutionarily conserved, alternative splicing of reelin during brain development. |
Volume: |
156 |
Issue: |
2 |
Pages: |
229-38 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yasui N |
Year: |
2007 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Structure of a receptor-binding fragment of reelin and mutational analysis reveal a recognition mechanism similar to endocytic receptors. |
Volume: |
104 |
Issue: |
24 |
Pages: |
9988-93 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hellwig S |
Year: |
2012 |
Journal: |
PLoS One |
Title: |
Reelin together with ApoER2 regulates interneuron migration in the olfactory bulb. |
Volume: |
7 |
Issue: |
11 |
Pages: |
e50646 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kohno T |
Year: |
2015 |
Journal: |
J Neurosci |
Title: |
Importance of Reelin C-terminal region in the development and maintenance of the postnatal cerebral cortex and its regulation by specific proteolysis. |
Volume: |
35 |
Issue: |
11 |
Pages: |
4776-87 |
|
•
•
•
•
•
|
Publication |
First Author: |
Brai E |
Year: |
2015 |
Journal: |
Front Cell Neurosci |
Title: |
Notch1 Regulates Hippocampal Plasticity Through Interaction with the Reelin Pathway, Glutamatergic Transmission and CREB Signaling. |
Volume: |
9 |
|
Pages: |
447 |
|
•
•
•
•
•
|
Publication |
First Author: |
Park C |
Year: |
2002 |
Journal: |
Genesis |
Title: |
The cerebellar deficient folia (cdf) gene acts intrinsically in Purkinje cell migrations. |
Volume: |
32 |
Issue: |
1 |
Pages: |
32-41 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jakob B |
Year: |
2017 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Intersectin 1 is a component of the Reelin pathway to regulate neuronal migration and synaptic plasticity in the hippocampus. |
Volume: |
114 |
Issue: |
21 |
Pages: |
5533-5538 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mata A |
Year: |
2017 |
Journal: |
Mol Neurobiol |
Title: |
Reelin Expression in Creutzfeldt-Jakob Disease and Experimental Models of Transmissible Spongiform Encephalopathies. |
Volume: |
54 |
Issue: |
8 |
Pages: |
6412-6425 |
|
•
•
•
•
•
|
Publication |
First Author: |
Park TJ |
Year: |
2008 |
Journal: |
J Neurosci |
Title: |
Crk and Crk-like play essential overlapping roles downstream of disabled-1 in the Reelin pathway. |
Volume: |
28 |
Issue: |
50 |
Pages: |
13551-62 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lawrenson ID |
Year: |
2017 |
Journal: |
Cereb Cortex |
Title: |
Cortical Layer Inversion and Deregulation of Reelin Signaling in the Absence of SOCS6 and SOCS7. |
Volume: |
27 |
Issue: |
1 |
Pages: |
576-588 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mota SI |
Year: |
2014 |
Journal: |
Exp Neurol |
Title: |
Impaired Src signaling and post-synaptic actin polymerization in Alzheimer's disease mice hippocampus--linking NMDA receptors and the reelin pathway. |
Volume: |
261 |
|
Pages: |
698-709 |
|
•
•
•
•
•
|
Publication |
First Author: |
Arnaud L |
Year: |
2003 |
Journal: |
Mol Cell Biol |
Title: |
Regulation of protein tyrosine kinase signaling by substrate degradation during brain development. |
Volume: |
23 |
Issue: |
24 |
Pages: |
9293-302 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jossin Y |
Year: |
2004 |
Journal: |
J Neurosci |
Title: |
The central fragment of Reelin, generated by proteolytic processing in vivo, is critical to its function during cortical plate development. |
Volume: |
24 |
Issue: |
2 |
Pages: |
514-21 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sharaf A |
Year: |
2013 |
Journal: |
PLoS One |
Title: |
ApoER2 and VLDLr are required for mediating reelin signalling pathway for normal migration and positioning of mesencephalic dopaminergic neurons. |
Volume: |
8 |
Issue: |
8 |
Pages: |
e71091 |
|
•
•
•
•
•
|
Publication |
First Author: |
Qiao S |
Year: |
2013 |
Journal: |
PLoS One |
Title: |
Dab2IP GTPase activating protein regulates dendrite development and synapse number in cerebellum. |
Volume: |
8 |
Issue: |
1 |
Pages: |
e53635 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang H |
Year: |
2008 |
Journal: |
J Clin Invest |
Title: |
AIP1 functions as an endogenous inhibitor of VEGFR2-mediated signaling and inflammatory angiogenesis in mice. |
Volume: |
118 |
Issue: |
12 |
Pages: |
3904-16 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
97
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
163
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Santana J |
Year: |
2017 |
Journal: |
Biochem J |
Title: |
The functions of Reelin in membrane trafficking and cytoskeletal dynamics: implications for neuronal migration, polarization and differentiation. |
Volume: |
474 |
Issue: |
18 |
Pages: |
3137-3165 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hass H |
Year: |
2017 |
Journal: |
PLoS One |
Title: |
Mathematical model of early Reelin-induced Src family kinase-mediated signaling. |
Volume: |
12 |
Issue: |
10 |
Pages: |
e0186927 |
|
•
•
•
•
•
|
Publication |
First Author: |
Stolt PC |
Year: |
2003 |
Journal: |
Structure |
Title: |
Origins of peptide selectivity and phosphoinositide binding revealed by structures of disabled-1 PTB domain complexes. |
Volume: |
11 |
Issue: |
5 |
Pages: |
569-79 |
|
•
•
•
•
•
|
Publication |
First Author: |
Blaikie P |
Year: |
1994 |
Journal: |
J Biol Chem |
Title: |
A region in Shc distinct from the SH2 domain can bind tyrosine-phosphorylated growth factor receptors. |
Volume: |
269 |
Issue: |
51 |
Pages: |
32031-4 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bork P |
Year: |
1995 |
Journal: |
Cell |
Title: |
A phosphotyrosine interaction domain. |
Volume: |
80 |
Issue: |
5 |
Pages: |
693-4 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kavanaugh WM |
Year: |
1994 |
Journal: |
Science |
Title: |
An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. |
Volume: |
266 |
Issue: |
5192 |
Pages: |
1862-5 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
Proteins encoding phosphotyrosine binding (PTB) domains function as adaptors or scaffolds to organise the signaling complexes involved in wide-ranging physiological processes including neural development, immunity, tissue homeostasis and cell growth. Due to structural differences, PTB domains are divided into three groups represented by phosphotyrosine-dependent IRS-like, phosphotyrosine-dependent Shc-like, and phosphotyrosine-independent Dab-like PTBs. The last two PTBs have been named as phosphotyrosine interaction domain (PID or PI domain). PID domain has an average length of about 160 amino acids [].The Shc-like PID specifically binds to the Asn-Pro-Xaa-Tyr(P) motif found in many tyrosine-phosphorylated proteins including growth factor receptors. On the other hand the Dab-like PID domain binds to non-phosphorylated tyrosine residue or even a phenylalanine at the same position []. Most of the ligands for Shc-like PID domains are RTK or cytokine, whereas phosphotyrosine independent Dab-like PID domains seems to mediate other types of signaling pathways, like endocytosis/processing or exocytosis. This domain binds both peptides and headgroups of phosphatidylinositides, utilising two distinct binding motifs to mediate spatial organisation and localisation within cells [, , , ].The 3D structure of PID domain has been solved []. It shares a folding pattern, commonly referred to as the PH-domain "superfold". The core "superfold"consists of seven antiparallel beta strands forming two orthogonal beta sheets. This beta sandwich is capped at the C terminus by an alpha helix. It contains a peptide binding pocket (formed by the beta strand 5 and C-terminal alpha helix) and a highly basic phospholipid binding "crown"(largely composed of residues from loop regions near the N terminus). Both Shcand Dab1 have two additional alpha helices, one of which is located at the Nterminus and the other between beta 1 and beta 2 strands. |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
308
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
304
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
503
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
200
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
588
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
766
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
235
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
271
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
548
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
304
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
148
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
110
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
548
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
214
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
745
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
76
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
548
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
383
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
455
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
299
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
147
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
59
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
236
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
113
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
527
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
330
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
228
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
160
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
163
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
634
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
258
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
839
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
527
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
766
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
555
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
188
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
453
 |
Fragment?: |
false |
|
•
•
•
•
•
|